After netting a $361 million…
After netting a $361 million series C funding round in [...]
After unsheathing just a few…
After unsheathing just a few months ago, Ollin Biosciences’ next-gen [...]
GSK has committed $50 million in…
GSK has committed $50 million in upfront capital and near-term [...]
Tessera Therapeutics is planning…
Tessera Therapeutics is planning to lay off 90 employees, the [...]
Protein degradation biotech…
Protein degradation biotech EpiBiologics has brought in $107 million in [...]
Amgen is getting down with Disco…
Amgen is getting down with Disco Pharmaceuticals, commissioning the German [...]
Rakuten Medical has added to its…
Rakuten Medical has added to its tally of mega-rounds, pocketing [...]
Soley Therapeutics has secured…
Soley Therapeutics has secured $200 million in series C funds, [...]
Eli Lilly has returned to Nimbus…
Eli Lilly has returned to Nimbus Therapeutics for another metabolic [...]
A pair of phase 3 psoriasis…
A pair of phase 3 psoriasis studies of Alumis’ TYK2 [...]